PACN2_HUMAN - dbPTM
PACN2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PACN2_HUMAN
UniProt AC Q9UNF0
Protein Name Protein kinase C and casein kinase substrate in neurons protein 2
Gene Name PACSIN2
Organism Homo sapiens (Human).
Sequence Length 486
Subcellular Localization Cytoplasm. Cytoplasm, cytoskeleton. Cytoplasmic vesicle membrane
Peripheral membrane protein
Cytoplasmic side. Early endosome. Recycling endosome membrane. Cell projection, ruffle membrane
Peripheral membrane protein
Cytoplasmic side. Cell membrane
P
Protein Description Lipid-binding protein that is able to promote the tubulation of the phosphatidic acid-containing membranes it preferentially binds. Plays a role in intracellular vesicle-mediated transport. Involved in the endocytosis of cell-surface receptors like the EGF receptor, contributing to its internalization in the absence of EGF stimulus. May also play a role in the formation of caveolae at the cell membrane. Recruits DNM2 to caveolae, and thereby plays a role in caveola-mediated endocytosis..
Protein Sequence MSVTYDDSVGVEVSSDSFWEVGNYKRTVKRIDDGHRLCSDLMNCLHERARIEKAYAQQLTEWARRWRQLVEKGPQYGTVEKAWMAFMSEAERVSELHLEVKASLMNDDFEKIKNWQKEAFHKQMMGGFKETKEAEDGFRKAQKPWAKKLKEVEAAKKAHHAACKEEKLAISREANSKADPSLNPEQLKKLQDKIEKCKQDVLKTKEKYEKSLKELDQGTPQYMENMEQVFEQCQQFEEKRLRFFREVLLEVQKHLDLSNVAGYKAIYHDLEQSIRAADAVEDLRWFRANHGPGMAMNWPQFEEWSADLNRTLSRREKKKATDGVTLTGINQTGDQSLPSKPSSTLNVPSNPAQSAQSQSSYNPFEDEDDTGSTVSEKDDTKAKNVSSYEKTQSYPTDWSDDESNNPFSSTDANGDSNPFDDDATSGTEVRVRALYDYEGQEHDELSFKAGDELTKMEDEDEQGWCKGRLDNGQVGLYPANYVEAIQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
39PhosphorylationDDGHRLCSDLMNCLH
CCHHHHHHHHHHHHH
38.07-
53AcetylationHERARIEKAYAQQLT
HHHHHHHHHHHHHHH
44.3025953088
53MalonylationHERARIEKAYAQQLT
HHHHHHHHHHHHHHH
44.3026320211
53UbiquitinationHERARIEKAYAQQLT
HHHHHHHHHHHHHHH
44.30-
72UbiquitinationRWRQLVEKGPQYGTV
HHHHHHHHCCCCCHH
69.30-
76PhosphorylationLVEKGPQYGTVEKAW
HHHHCCCCCHHHHHH
20.2128152594
78PhosphorylationEKGPQYGTVEKAWMA
HHCCCCCHHHHHHHH
22.1328152594
88PhosphorylationKAWMAFMSEAERVSE
HHHHHHHCHHHHHHH
27.48-
105SulfoxidationLEVKASLMNDDFEKI
HHHHHHHCCCCHHHH
4.8421406390
111UbiquitinationLMNDDFEKIKNWQKE
HCCCCHHHHHHHHHH
60.00-
117AcetylationEKIKNWQKEAFHKQM
HHHHHHHHHHHHHHH
42.5019608861
117UbiquitinationEKIKNWQKEAFHKQM
HHHHHHHHHHHHHHH
42.5019608861
122MalonylationWQKEAFHKQMMGGFK
HHHHHHHHHHHCCHH
33.1732601280
129AcetylationKQMMGGFKETKEAED
HHHHCCHHHCHHHHH
68.6825953088
129UbiquitinationKQMMGGFKETKEAED
HHHHCCHHHCHHHHH
68.68-
131PhosphorylationMMGGFKETKEAEDGF
HHCCHHHCHHHHHHH
34.4730576142
1672-HydroxyisobutyrylationHAACKEEKLAISREA
HHHHHHHHHHHHHHH
44.29-
167UbiquitinationHAACKEEKLAISREA
HHHHHHHHHHHHHHH
44.29-
171 (in isoform 2)Phosphorylation-20.6124719451
171PhosphorylationKEEKLAISREANSKA
HHHHHHHHHHHHCCC
20.6124719451
176PhosphorylationAISREANSKADPSLN
HHHHHHHCCCCCCCC
35.9528122231
177 (in isoform 2)Ubiquitination-57.5321906983
177 (in isoform 1)Ubiquitination-57.5321906983
177UbiquitinationISREANSKADPSLNP
HHHHHHCCCCCCCCH
57.532190698
181PhosphorylationANSKADPSLNPEQLK
HHCCCCCCCCHHHHH
41.1328122231
188UbiquitinationSLNPEQLKKLQDKIE
CCCHHHHHHHHHHHH
51.65-
193AcetylationQLKKLQDKIEKCKQD
HHHHHHHHHHHHHHH
39.5425953088
213UbiquitinationEKYEKSLKELDQGTP
HHHHHHHHHHHCCCH
64.42-
213 (in isoform 2)Ubiquitination-64.42-
263 (in isoform 2)Phosphorylation-6.3627642862
264UbiquitinationLSNVAGYKAIYHDLE
HHHCCCHHHHHHCHH
27.65-
267PhosphorylationVAGYKAIYHDLEQSI
CCCHHHHHHCHHHHH
8.30-
267 (in isoform 2)Phosphorylation-8.3027642862
273PhosphorylationIYHDLEQSIRAADAV
HHHCHHHHHHHHHHH
12.5023186163
284MethylationADAVEDLRWFRANHG
HHHHHHHHHHHHHCC
42.69115486319
294SulfoxidationRANHGPGMAMNWPQF
HHHCCCCCCCCCHHH
3.4430846556
296SulfoxidationNHGPGMAMNWPQFEE
HCCCCCCCCCHHHHH
3.9130846556
305PhosphorylationWPQFEEWSADLNRTL
CHHHHHHHHHHHHHH
18.3822167270
311 (in isoform 2)Phosphorylation-28.1924719451
311PhosphorylationWSADLNRTLSRREKK
HHHHHHHHHCHHHHH
28.1922167270
313PhosphorylationADLNRTLSRREKKKA
HHHHHHHCHHHHHHC
28.7822167270
313 (in isoform 2)Phosphorylation-28.7824719451
321PhosphorylationRREKKKATDGVTLTG
HHHHHHCCCCEEEEE
42.0125159151
325 (in isoform 2)Phosphorylation-24.9230108239
327 (in isoform 2)Phosphorylation-27.0128450419
332 (in isoform 2)Phosphorylation-37.9328450419
336 (in isoform 2)Phosphorylation-47.1628450419
336PhosphorylationINQTGDQSLPSKPSS
ECCCCCCCCCCCCCC
47.1625159151
339 (in isoform 2)Phosphorylation-63.5923663014
339PhosphorylationTGDQSLPSKPSSTLN
CCCCCCCCCCCCCCC
63.5924719451
342 (in isoform 2)Phosphorylation-39.4323663014
342PhosphorylationQSLPSKPSSTLNVPS
CCCCCCCCCCCCCCC
39.4322199227
343 (in isoform 2)Phosphorylation-45.5023663014
343PhosphorylationSLPSKPSSTLNVPSN
CCCCCCCCCCCCCCC
45.5022199227
344PhosphorylationLPSKPSSTLNVPSNP
CCCCCCCCCCCCCCH
27.0422199227
345 (in isoform 2)Phosphorylation-7.0325849741
346 (in isoform 2)Phosphorylation-43.6825849741
347 (in isoform 2)Phosphorylation-6.5523663014
354PhosphorylationVPSNPAQSAQSQSSY
CCCCHHHCCCCCCCC
30.3130576142
357PhosphorylationNPAQSAQSQSSYNPF
CHHHCCCCCCCCCCC
31.5730576142
359PhosphorylationAQSAQSQSSYNPFED
HHCCCCCCCCCCCCC
39.7830576142
360PhosphorylationQSAQSQSSYNPFEDE
HCCCCCCCCCCCCCC
22.6930576142
361PhosphorylationSAQSQSSYNPFEDED
CCCCCCCCCCCCCCC
31.9128270605
370PhosphorylationPFEDEDDTGSTVSEK
CCCCCCCCCCCCCCC
45.4125159151
372PhosphorylationEDEDDTGSTVSEKDD
CCCCCCCCCCCCCCC
27.9425159151
373PhosphorylationDEDDTGSTVSEKDDT
CCCCCCCCCCCCCCC
29.4225159151
375PhosphorylationDDTGSTVSEKDDTKA
CCCCCCCCCCCCCCC
38.7325159151
380PhosphorylationTVSEKDDTKAKNVSS
CCCCCCCCCCCCCCC
42.9330576142
383UbiquitinationEKDDTKAKNVSSYEK
CCCCCCCCCCCCCCC
60.48-
386PhosphorylationDTKAKNVSSYEKTQS
CCCCCCCCCCCCCCC
36.2721712546
387PhosphorylationTKAKNVSSYEKTQSY
CCCCCCCCCCCCCCC
32.7828796482
388PhosphorylationKAKNVSSYEKTQSYP
CCCCCCCCCCCCCCC
17.5928796482
391PhosphorylationNVSSYEKTQSYPTDW
CCCCCCCCCCCCCCC
15.7125850435
393PhosphorylationSSYEKTQSYPTDWSD
CCCCCCCCCCCCCCC
38.0123927012
394PhosphorylationSYEKTQSYPTDWSDD
CCCCCCCCCCCCCCC
10.5923927012
394 (in isoform 2)Phosphorylation-10.5927642862
396PhosphorylationEKTQSYPTDWSDDES
CCCCCCCCCCCCCCC
41.7023927012
396 (in isoform 2)Phosphorylation-41.7027642862
399PhosphorylationQSYPTDWSDDESNNP
CCCCCCCCCCCCCCC
37.6826503892
403PhosphorylationTDWSDDESNNPFSST
CCCCCCCCCCCCCCC
49.2323927012
408PhosphorylationDESNNPFSSTDANGD
CCCCCCCCCCCCCCC
33.3223927012
409PhosphorylationESNNPFSSTDANGDS
CCCCCCCCCCCCCCC
30.5926657352
410PhosphorylationSNNPFSSTDANGDSN
CCCCCCCCCCCCCCC
37.6225137130
416PhosphorylationSTDANGDSNPFDDDA
CCCCCCCCCCCCCCC
48.0428464451
424PhosphorylationNPFDDDATSGTEVRV
CCCCCCCCCCCEEEE
34.3828188228
425PhosphorylationPFDDDATSGTEVRVR
CCCCCCCCCCEEEEE
45.5025850435
427PhosphorylationDDDATSGTEVRVRAL
CCCCCCCCEEEEEEE
30.9523927012
446PhosphorylationGQEHDELSFKAGDEL
CCCCCEEEECCCCCC
23.7425159151
455UbiquitinationKAGDELTKMEDEDEQ
CCCCCCCCCCCCCCC
53.57-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
313SPhosphorylationKinasePKC-Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PACN2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PACN2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PACN3_HUMANPACSIN3physical
11082044
PACN1_HUMANPACSIN1physical
16189514
PACN2_HUMANPACSIN2physical
16189514
TNFL6_HUMANFASLGphysical
12023017
DYN1_HUMANDNM1physical
11082044
SYNJ1_HUMANSYNJ1physical
11082044
WASL_HUMANWASLphysical
11082044
PACN1_HUMANPACSIN1physical
11082044
PACN2_HUMANPACSIN2physical
11082044
SYCC_HUMANCARSphysical
19041431
CYFP2_HUMANCYFIP2physical
19041431
ASAP1_HUMANASAP1physical
19041431
DYN2_HUMANDNM2physical
19041431
HSP7C_HUMANHSPA8physical
19041431
KHDR1_HUMANKHDRBS1physical
19041431
MILK1_HUMANMICALL1physical
19041431
AB1IP_HUMANAPBB1IPphysical
19041431
WASP_HUMANWASphysical
19041431
WIPF1_HUMANWIPF1physical
19041431
SBK1_HUMANSBK1physical
19041431
ANS1A_HUMANANKS1Aphysical
22863883
2A5G_HUMANPPP2R5Cphysical
22863883
SWP70_HUMANSWAP70physical
22863883
PACN2_HUMANPACSIN2physical
25416956
PACN1_HUMANPACSIN1physical
25416956
COBL_HUMANCOBLphysical
26186194
COBL1_HUMANCOBLL1physical
26186194
THG1_HUMANTHG1Lphysical
26186194
WIPF2_HUMANWIPF2physical
26186194
MPRIP_HUMANMPRIPphysical
26186194
CH60_HUMANHSPD1physical
26344197
COBL_HUMANCOBLphysical
28514442
COBL1_HUMANCOBLL1physical
28514442
THG1_HUMANTHG1Lphysical
28514442
MPRIP_HUMANMPRIPphysical
28514442
WIPF2_HUMANWIPF2physical
28514442
RAI14_HUMANRAI14physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PACN2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-117, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-370; SER-372; THR-373AND SER-375, AND MASS SPECTROMETRY.

TOP